LILRA3/CD85e Rabbit pAb, PE-Cy7 conjugated
LILRA3/CD85e Rabbit pAb, PE-Cy7 conjugated is a PE/Cy7 conjugated antibody targeting LILRA3. This antibody is suitable for ICC, IF.
Product Specifications
Product Name Alternative
CD 85E; CD85 antigen-like family member E; CD85e; CD85e antigen; e3; HM 31; HM 43; HM31; HM43; ILT 6; ILT-6; ILT6; Immunoglobulin like transcript 6; Immunoglobulin-like transcript 6; Leucocyte immunoglobulin like receptor; Leukocyte immunoglobulin like receptor 4; Leukocyte immunoglobulin like receptor A3; Leukocyte immunoglobulin like receptor subfamily A (without TM domain) member 3; Leukocyte immunoglobulin like receptor subfamily A member 3; Leukocyte immunoglobulin-like receptor 4; Leukocyte immunoglobulin-like receptor subfamily A member 3; LILRA 3; LILRA3; LIR 4; LIR-4; LIR4; LIRA3_HUMAN; Monocyte inhibitory receptor HM43/HM31.
Immunogen
KLH conjugated synthetic peptide derived from human LILRA3/CD85e (311-400/439aa)
Target
LILRA3
Clonality
Polyclonal
Conjugation
PE/Cy7
Field of Research
Immunology & Inflammation
Purification
Affinity purified by Protein A
Concentration
1mg/ml
Dilution
ICC/IF=1:50-200, IF=1:100-500
Storage Conditions
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
Prediction Reactivity
Human
Tested Applications
ICC, IF
Host or Source
Rabbit
Preservative
0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
L5999-33-ML750 100 µL
Luciferase (Luciferin 4-monooxygenase) (MaxLight 750) discontinued
Sign In for Pricing
View Details 